Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Precision of 3 Dimensional Facial Analysis Using Bellus 3D Face Camera Pro Versus Planmeca ProMax 3D Proface: A Diagnostic Accuracy Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04511598
Recruitment Status : Recruiting
First Posted : August 13, 2020
Last Update Posted : August 13, 2020
Sponsor:
Information provided by (Responsible Party):
Sally Faisal Mahmoud Fouad Abdallah, Cairo University

Brief Summary:
Precision of 3 Dimensional Facial Analysis Using "Bellus 3D Face Camera Pro" Versus "Planmeca ProMax 3D Proface" is to be evaluated in comparison to direct anthropometry.

Condition or disease Intervention/treatment Phase
3 Dimensional Soft Tissue Facial Analysis Device: "Bellus 3D Face Camera" Device: "Planmeca ProMax 3D Proface" Not Applicable

Detailed Description:
The aim of this study will be the evaluation of the precision and reproducibility of standard anthropometric linear measurements made with two different three-dimensional imaging systems namely "Bellus 3D Face Camera Pro" and "Planmeca ProMax 3D ProFace system" and to compare them to physical linear measurements "Direct Anthropometry".

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Diagnostic
Official Title: Precision of 3 Dimensional Facial Analysis Using Bellus 3D Face Camera Pro Versus Planmeca ProMax 3D Proface: A Diagnostic Accuracy Study
Actual Study Start Date : March 1, 2020
Estimated Primary Completion Date : March 2021
Estimated Study Completion Date : August 2021

Arm Intervention/treatment
Experimental: Bellus 3D Face Camera Pro
Every single patient will be diagnosed using 3D imaging system "Bellus 3D Face Camera Pro" to be compared to the direct measurements obtained from direct anthropometry.
Device: "Bellus 3D Face Camera"
The depth sensor uses infrared structured light scanning technology to capture depth and the camera on the phone or tablet to capture color texture of the face.

Device: "Planmeca ProMax 3D Proface"
The lasers scan the facial geometry and the digital cameras capture the color texture of the face.

Experimental: Planmeca ProMax 3D Proface
Every single patient will be diagnosed using 3D imaging systems "Planmeca ProMax 3D Proface" to be compared to the direct measurements obtained from direct anthropometry.
Device: "Bellus 3D Face Camera"
The depth sensor uses infrared structured light scanning technology to capture depth and the camera on the phone or tablet to capture color texture of the face.

Device: "Planmeca ProMax 3D Proface"
The lasers scan the facial geometry and the digital cameras capture the color texture of the face.




Primary Outcome Measures :
  1. Precision [ Time Frame: 1 Month ]
    Evaluation of the precision of standard anthropometric linear measurements made with two different three-dimensional imaging systems namely Bellus 3D Face Camera Pro and Planmeca ProMax 3D ProFace system and to compare them to physical linear measurements.


Secondary Outcome Measures :
  1. Reproducibility [ Time Frame: 1 Month ]
    Evaluation of the reproducibility of standard anthropometric linear measurements made with two different three-dimensional imaging systems namely Bellus 3D Face Camera Pro and Planmeca ProMax 3D ProFace system and to compare them to physical linear measurements.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Age range from 18-35 years.
  2. Normal balanced facial proportions.

Exclusion Criteria:

  1. Craniofacial anomalies.
  2. Obvious skeletal shifts.
  3. Patients with incompetent lips.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04511598


Contacts
Layout table for location contacts
Contact: Sally Faisal Mahmoud Fouad Abdallah +2 01061152623 sallyfaisalmira@gmail.com

Locations
Layout table for location information
Egypt
Faculty of dentistry Recruiting
Cairo, Giza, Egypt, 12511
Contact: Sally Faisal Mahmoud Fouad Abdallah    +201061152623    sallyfaisalmira@gmail.com   
Sponsors and Collaborators
Cairo University
Layout table for additonal information
Responsible Party: Sally Faisal Mahmoud Fouad Abdallah, Masters Degree Student, Cairo University
ClinicalTrials.gov Identifier: NCT04511598    
Other Study ID Numbers: ORTH 7-1-2
First Posted: August 13, 2020    Key Record Dates
Last Update Posted: August 13, 2020
Last Verified: August 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Facies
Disease Attributes
Pathologic Processes